Image

Global Nasal Polyps Treatment Market – Industry Trends and Forecast to 2028

  • Pharmaceutical
  • Upcoming Report
  • Nov 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Nasal Polyps Treatment Market, By Type (Ethmoidal Polyp, Antrochoanal Polyp, Others), Related Diseases (Chronic Sinusitis, Cystic Fibrosis (CF), Allergic Fungal Sinusitis (AFS), Others), Treatment (Pharmacological Therapies, Surgeries), Complications (Obstructive Sleep Apnea, Sinus Infections, Others), Drug Class (Corticosteroids, Antibiotics, Leukotriene Inhibitors, Others), Diagnosis (Nasal Endoscopy, Blood Test, Allergy Tests, Others), Treatment (Medication, Surgery, Others), Medication (Nasal Corticosteroids, Medication to Treat Nasal Polyps and Chronic Sinusitis, Others), Route of Administration (Oral, Injectable, Others), End Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.

Nasal Polyps Treatment Market Market Analysis and Insights : Global Nasal Polyps Treatment Market

Nasal polyp treatment market size is projected to grow at a compound annual growth rate of 5.3% over the forecast period of 2021 to 2028. Data Bridge Market Research report on nasal polyps treatment market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecasted period while providing their impacts on the market’s growth.

Nasal polyps is growth or swellings which basically formed in the lining of the nose and paranasal sinuses. They are usually non-painful and caused due to long-term inflammation or by genetic traits. They are generally non-cancerous and obstruct the pathway of sinuses. The treatment of nasal polyps is sub-segmented into medication, surgery and others.

The rapid increasing geriatric population that are more vulnerable for development of nasal polyps and increasing prevalence of diseases such as asthma, chronic rhinosinusitis, nasal polyps, and allergic rhinitis across the globe is expected to accelerate the market growth in the forecast period of 2021 to 2028. Furthermore, growing screening for diagnosis of asymptomatic diseases like nasal polyps and rising awareness about the disease and its complications will further carve the way for the growth of the market. However, low healthcare expenditure in some countries is projected to restraint the market growth rate.

 In addition, the growing research and development activities and development of minimally-invasive surgical treatments and therapies are likely to create various new opportunities that will impact this nasal polyps treatment market growth in the forecast period of 2021 to 2028.The bleeding and infection during surgery are estimated to challenge the market’s growth.

This nasal polyp’s treatment market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the nasal polyps treatment market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Nasal polyps Treatment Market Scope and Market Size

Nasal polyps’ treatment market is segmented on the basis of types, mechanism of action, drugs, treatment, route of administration, distribution channel and end-users. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of type, the market is segmented into ethmoidal polyp, antrochoanal polyp and others.
  • On the basis of related diseases, the nasal polyp’s treatment market is segmented into chronic sinusitis, cystic fibrosis (CF), allergic fungal sinusitis (AFS) and others.
  • On the basis of complications, the market is bifurcated into obstructive sleep apnea, sinus infections and others.
  • On the basis of drug class, the nasal polyp’s treatment market is segmented into corticosteroids, antibiotics, leukotriene inhibitors and others.
  • Based on diagnosis, the market is segregated into nasal endoscopy, blood test, allergy tests and others.
  • On the basis of treatment, the market is segmented into medication, surgery and others.
  • On the basis of medication, the nasal polyp’s treatment market is segmented into nasal corticosteroids, medication to treat nasal polyps and chronic sinusitis and others.
  • On the basis of route of administration, the market is segmented into oral, injectable and others.
  • On the basis of end users, the nasal polyp’s treatment market is segmented into hospitals, homecare, specialty clinics and others.
  • On the basis of distribution channel, the market is segmented into hospital pharmacy, online pharmacy, retail pharmacy, others.

Nasal Polyps Treatment Market Country Level Analysis

Nasal polyps’ treatment market is analyzed and market size information is provided by types, mechanism of action, drugs, treatment, route of administration, distribution channel and end-users as referenced above.

The countries covered in the nasal polyps treatment market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America leads the nasal polyp’s treatment market due to the increase in incidences of CRSwNP, high prevalence of nasal polyps and rapid adoption of technologically-advanced products such as sinus implants. Asia-Pacific region is expected to expand at a significant growth rate in the forecast period of 2021 to 2028 because of the surge in the target patient pool with inflammatory respiratory disorders and rising the cases of sinus surgeries.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Nasal polyp’s treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Nasal polyps Treatment Market Share Analysis

Nasal polyp’s treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to nasal polyp’s treatment market.

The major players covered in the nasal polyps treatment market report are Regeneron Pharmaceuticals, Inc., Novartis AG, GlaxoSmithKline plc., OptiNose US, Inc., Lyra Therapeutics, Intersect ENT, Inc., Merck & Co Inc., Teva Pharmaceutical Industries Ltd., Sanofi, F. Hoffmann-La Roche Ltd, Blacksmith Surgical, Pfizer Inc., Bausch Health, Alkermes, AstraZeneca, Mallinckrodt, Dr. Reddy’s Laboratories Ltd, Lonza among other domestic and global players. Nasal polyp’s treatment market share data is available for global, North America, South America, Europe, Asia-Pacific (APAC) and Middle East and Africa (MEA) separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available : Global Nasal Polyps Treatment Market     

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions